Atezolizumab‐Induced Immune‐Related Pneumonia on Rounded Atelectasis

Atezolizumab‐Induced Immune‐Related Pneumonia on Rounded Atelectasis

Saved in:

Bibliographic Details
Main Authors:	Satoru Yanagisawa, Takaya Yui, Hiroki Takechi, Satoshi Wasamoto
Format:	Article
Language:	English
Published:	Wiley 2024-09-01
Series:	The Clinical Respiratory Journal
Subjects:	asbestos exposure atezolizumab immune‐related adverse events rounded atelectasis small‐cell lung cancer
Online Access:	https://doi.org/10.1111/crj.70008
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Endotracheal N-acetylcysteine for Atelectasis in Neonatal Pneumonia
by: Mustafa Dilek, et al.
Published: (2019-12-01)

Effect of high-flow nasal cannula oxygen therapy on the postoperative atelectasis in interventional sclerotherapy: a randomized controlled trial
by: Mai Zifeng, et al.
Published: (2025-07-01)

Effect of visual lung recruitment manoeuvres guided by trans-oesophageal lung ultrasound on atelectasis after thoracoscopic lobectomy: a randomised, single-blind, prospective study
by: Furong Bai, et al.
Published: (2024-10-01)

Left upper lobe atelectasis due to plastic bronchitis
by: Tuğba Şişmanlar, et al.
Published: (2017-04-01)

Incentive spirometry as a way to prevent pulmonary atelectasis development
by: T. S. Kuzmenko, et al.
Published: (2019-04-01)

Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
by: Amparo Burgos-San José, et al.
Published: (2021-05-01)

Case Report: A neonatal case of severe congenital Mycoplasma pneumoniae pneumonia with atelectasis and macrolide resistance
by: Dan Wang, et al.
Published: (2025-06-01)

Atezolizumab in the treatment of small cell lung cancer
by: Kacper Ordon, et al.
Published: (2025-06-01)

Risk assessment of postoperative atelectasis in elderly lung cancer patients undergoing thoracoscopic surgery based on a nomogram model
by: Bin Liu, et al.
Published: (2025-05-01)

Cost-effectiveness of atezolizumab versus chemotherapy in patients with non-small-cell lung cancer ineligible for platinum-based doublet chemotherapy
by: Qiuji Wu, et al.
Published: (2025-05-01)

Respiratory Physiotherapy Interventions in Paediatric Population with Atelectasis: A Systematic Review
by: Carlota Beatriz Esteban-Gavilán, et al.
Published: (2024-11-01)

Chronic Right Middle Lobe Atelectasis in Ambulatory Children
by: Kin-Sun Wong, et al.
Published: (2019-10-01)

Case report: refractory atelectasis after infection of adenovirus and Mycoplasma Pneumoniae in an immunocompetent patient
by: Xuehua Xu, et al.
Published: (2025-05-01)

Atezolizumab-Induced Ulcerative Colitis in Patient with Hepatocellular Carcinoma: Case Report and Literature Review
by: Hyuk Kim, et al.
Published: (2024-08-01)

Combination therapy with expanded natural killer cells and atezolizumab exerts potent antitumor immunity in small cell lung cancer
by: Manh-Cuong Vo, et al.
Published: (2025-03-01)

Occupational exposure to ultrafine particles and lung cancer in a population exposed to asbestos
by: Carine Rostello, et al.
Published: (2025-02-01)

Atelectasis predicts poor prognosis in pediatric macrolides-unresponsive Mycoplasma pneumoniae pneumonia with A2063/2064G mutations treated with azithromycin
by: Jie Cheng, et al.
Published: (2025-06-01)

Assessment of asbestos exposure in Kyrgyzstan through analysis of raw and processed materials, air samples and human lung tissue
by: Zhyldyz Kurzhunbaeva, et al.
Published: (2025-07-01)

Advances in epidemiology and population-based prevention and control of cancers caused by asbestos exposure
by: Huang Qiulin, et al.
Published: (2025-06-01)

Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
by: K. Morimoto, et al.
Published: (2025-06-01)

Case Report: From diagnosis to therapy: a lung ultrasound-driven precision strategy for neonatal atelectasis management
by: Qi Chen, et al.
Published: (2025-06-01)

Vestibular Atelectasis: A Narrative Review and Our Experience
by: Andrea Tozzi, et al.
Published: (2025-05-01)

Characterization of Asbestos in Ambient Air During Refractory Material Production from Magnesite Ore
by: Mehmet Ali Küçüker
Published: (2021-09-01)

Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer
by: I. S. Krysanov, et al.
Published: (2023-11-01)

Development and validation of a nomogram to predict atelectasis in adult lymph node fistula tracheobronchial tuberculosis patients
by: Quhua Yin, et al.
Published: (2025-08-01)

Improved Discriminability of Severe Lung Injury and Atelectasis in Thoracic Trauma at Low keV Virtual Monoenergetic Images from Photon-Counting Detector CT
by: Hanns Leonhard Kaatsch, et al.
Published: (2024-10-01)

PD-1/PD-L1 blockade therapy with atezolizumab: a new paradigm in the treatment of non-small cell lung cancer (NSCLC)
by: Samaneh Moradi, et al.
Published: (2025-03-01)

A four-miRNA signature as a potential biomarker of malignant mesothelioma patients from hand-spinning asbestos exposed area in Eastern China
by: Lijin Zhu, et al.
Published: (2025-07-01)

Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment
by: F. Rossari, et al.
Published: (2025-06-01)

Combining intraprocedural CT guided navigation with ventilatory strategy for atelectasis: A modified electromagnetic navigation bronchoscopy
by: Shaohua Dai, et al.
Published: (2024-01-01)

Mortality from Pleural and Lung Cancer in Railway Maintenance Workers
by: Leonardo Scarso, et al.
Published: (2025-07-01)

Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma
by: Shaobo Zhang, et al.
Published: (2025-05-01)

The association between neostigmine and postoperative atelectasis in elderly patients undergoing laparoscopic pancreaticoduodenectomy: a retrospective single-center propensity score matched study
by: Rong Luo, et al.
Published: (2025-06-01)

Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapy
by: Ryosuke Tsunemitsu, et al.
Published: (2023-06-01)

Brain hemorrhage in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
by: Bangju Kim, et al.
Published: (2025-06-01)

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01)

Safety and efficacy of atezolizumab/bevacizumab in unresectable hepatocellular carcinoma—a multicentric study
by: Merin Babu, et al.
Published: (2025-07-01)

Gender- and Age-Associated Variations in the Prevalence of Atelectasis, Effusion, and Nodules on Chest Radiographs: A Large-Scale Analysis Using the NIH ChestX-Ray8
by: Josef Yayan, et al.
Published: (2025-05-01)

Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC
by: Risako Kohya, et al.
Published: (2025-05-01)

Effect of driving pressure-guided individualized positive end-expiratory pressure (PEEP) ventilation strategy on postoperative atelectasis in patients undergoing laparoscopic surgery as assessed by ultrasonography: study protocol for a prospective randomized controlled trial
by: Yi Zhang, et al.
Published: (2025-03-01)